Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Detection of Intracellular Complement Activation in Human T Lymphocytes: Version 1

In: National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]. Bethesda (MD): National Cancer Institute (US); 2005 May. NCL Method ITA-26.
2019 Feb.
Affiliations
Free Books & Documents
Review

Detection of Intracellular Complement Activation in Human T Lymphocytes: Version 1

Anna N. Ilinskaya et al.
Free Books & Documents

Excerpt

The complement present in plasma is a group of approximately 30 proteins which are produced by the liver. Plasma complement plays an important role in innate immunity and promotes adaptive immunity against pathogens. Activation of plasma complement may occur in response to a drug product. Such undesirable activation results in immediate-type hypersensitivity reactions independent of immunoglobulin E. These reactions are often referred to as Complement Activation Related Pseudoallergy (CARPA). Although CARPA has been observed in the clinic with various types of drug products, nanoformulations, and especially PEGylated liposomes, are frequent causes of CARPA in patients [1, 2].

Activation of plasma complement is initiated via three main pathways, the classical, the alternative and the lectin pathway, all of which converge at the complement component 3 (C3) to form a common, terminal pathway leading to the formation of the membrane attack complex [3]. Cleavage of C3, C4 and C5 components of the plasma complement results in generation of several split products, C3a, C4a, and C5a, which are also known as anaphylatoxins. The anaphylatoxins are the main triggers of the symptoms observed in CARPA. The larger split products (C3b, C4b, and C5b) are opsonins which bind to and accelerate the clearance of pathogens.

Recently, the concept of complement has been expanded to include so-called intracellular complement [4]. The complement protein C3 has been found in many cells including lymphocytes, monocytes, endothelial and even cancer cells. The activation of intracellular complement generates split products which are exported from the cell onto the membrane. Since the activation of intracellular complement in T-lymphocytes was found to correlate with autoimmune disorders [4], and growing evidence is available for the involvement of T-lymphocytes in the development of drug-induced hypersensitivity reactions [5], understanding the ability of nanomaterials to activate intracellular complement may aid in establishing long-term safety profiles for these materials.

PubMed Disclaimer

Similar articles

References

    1. Szebeni J, Alving CR, Rosivall L et al..: Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res 17(2), 107–117 (2007). - PubMed
    1. Salvador-Morales C, Sim RB: Complement activation. In: Handbook of immunological properties of engineered nanomaterials, Dobrovolskaia MA, Mcneil SE (Eds). World Scientific, Singapore: 357–384 (2013).
    1. Sahu A, Lambris JD: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180, 35–48 (2001). - PubMed
    1. Liszewski MK, Kolev M, Le Friec G et al..: Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 39(6), 1143–1157 (2013). - PMC - PubMed
    1. Pavlos R, Mallal S, Ostrov D et al..: T Cell-Mediated Hypersensitivity Reactions to Drugs. Annu Rev Med, (2014). - PMC - PubMed

LinkOut - more resources